Prediction: This Quantum Computing Stock Is Going to Plummet in the Second Half of 2026

Rigetti Computing is set to receive a $100 million U.S. government investment over three years, but the article argues the stock remains risky at a $7 billion valuation. Q1 revenue rose 198% year over year to $4.4 million, yet Rigetti posted a $20.5 million GAAP net loss and carried $569 million in cash as of March 31. The piece warns that lumpy revenue, ongoing losses, and a forward P/S near 300 could leave the stock vulnerable to a 50%+ decline in the second half of 2026.

Analysis

The market is likely misreading the government stake as a near-term commercialization signal when it is really a runway-extension event. For a pre-scale hardware platform, that matters less for intrinsic value than for timing: the subsidy lowers bankruptcy probability and may support more issuance windows, but it does not solve the core problem that unit economics remain dominated by error correction and low utilization. In practice, the policy backstop can paradoxically make the equity more fragile in 6-18 months because it delays the cleansing event that would otherwise reset expectations.

The second-order winner is not the incumbent public name, but the enabling stack around it: cryogenics, specialty semis, measurement equipment, and government contractors that can sell into a broader U.S. quantum buildout without taking direct technical risk. Within the quantum cohort, the better relative trade is the company with the strongest balance sheet and clearest path to recurring cloud access revenue, not the one with the highest headline qubit count. If spend is spread across nine names, the signal to customers is also that no single platform has won; that reduces “winner-take-all” pricing power and increases the odds of multiple capital raises across the group.

The key catalyst window is 2H26 into 2027, when the market will stop paying for narrative and start rewarding proof of repeatable bookings. If revenue remains lumpy while losses stay elevated, the equity becomes a financing story rather than a technology story, and that typically compresses multiples sharply. The contrarian risk to being outright bearish is that a second government tranche, defense-linked contract, or strategic partnership could re-rate the stock again before fundamentals catch up, so timing matters more than direction.

Key Decisions for Investors

• Short RGTI into strength on any post-government-news squeeze; use a 3-6 month horizon and treat the position as a valuation/timing fade rather than a fundamental zero. Risk/reward improves if the stock remains >20x forward sales equivalent on updated estimates, but cover quickly if a new strategic customer or federal follow-on contract is announced.
• Prefer a pair trade: long the strongest balance-sheet quantum infrastructure enabler / pick-and-shovel supplier basket, short RGTI, to isolate industry adoption from single-name execution risk. This should outperform over 6-12 months if quantum spend broadens but commercial traction remains uneven.
• Buy medium-dated puts or put spreads on RGTI for the 2H26 catalyst window, targeting the period when financing risk and missed-revenue scrutiny can matter more than policy headlines. Structure for limited premium outlay because implied volatility is likely already elevated.
• Avoid chasing the entire quantum theme indiscriminately; use the government funding as a signal to trim exposure in the most diluted, least commercialized names and rotate into firms with recurring revenue or defense adjacency. The risk is that policy optics keep weak names elevated longer than fundamentals warrant.
• Set a trigger-based reassessment: if cash burn is not visibly moderated or backlog does not convert into repeat orders within the next 2-3 quarters, increase bearish exposure. If a major defense/customer validation event lands, reduce shorts immediately because narrative-driven rerating can be violent.